546 related articles for article (PubMed ID: 15059929)
21. The serotonin transporter: a vehicle to elucidate pulmonary hypertension?
Weir EK; Hong Z; Varghese A
Circ Res; 2004 May; 94(9):1152-4. PubMed ID: 15142967
[No Abstract] [Full Text] [Related]
22. The serotonin receptor and transporter as potential therapeutic targets for pulmonary hypertension.
Wang HL
Curr Opin Investig Drugs; 2004 Sep; 5(9):963-6. PubMed ID: 15503652
[TBL] [Abstract][Full Text] [Related]
23. [Implication of serotonin in the control of vigilance states as revealed by knockout-mouse studies].
Adrien J
J Soc Biol; 2004; 198(1):30-6. PubMed ID: 15146953
[TBL] [Abstract][Full Text] [Related]
24. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
[TBL] [Abstract][Full Text] [Related]
25. Repeat length polymorphism of the serotonin transporter gene influences pulmonary artery pressure in heart failure.
Olson TP; Snyder EM; Frantz RP; Turner ST; Johnson BD
Am Heart J; 2007 Mar; 153(3):426-32. PubMed ID: 17307423
[TBL] [Abstract][Full Text] [Related]
26. Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertension.
Rabinovitch M
J Clin Invest; 2001 Oct; 108(8):1109-11. PubMed ID: 11602617
[No Abstract] [Full Text] [Related]
27. Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: evidence from auditory cortical stimulus processing.
Gallinat J; Kunz D; Lang UE; Kalus P; Juckel G; Eggers J; Mahlberg R; Staedtgen M; Wernicke C; Rommelspacher H; Smolka MN
Pharmacopsychiatry; 2005 Jul; 38(4):158-60. PubMed ID: 16025417
[TBL] [Abstract][Full Text] [Related]
28. The 5-HT transporter transactivates the PDGFbeta receptor in pulmonary artery smooth muscle cells.
Liu Y; Li M; Warburton RR; Hill NS; Fanburg BL
FASEB J; 2007 Sep; 21(11):2725-34. PubMed ID: 17504974
[TBL] [Abstract][Full Text] [Related]
29. Reduced aggression in mice lacking the serotonin transporter.
Holmes A; Murphy DL; Crawley JN
Psychopharmacology (Berl); 2002 May; 161(2):160-7. PubMed ID: 11981596
[TBL] [Abstract][Full Text] [Related]
30. Association of serotonin transporter gene polymorphism with obstructive sleep apnea syndrome.
Ylmaz M; Bayazit YA; Ciftci TU; Erdal ME; Urhan M; Kokturk O; Kemaloglu YK; Inal E
Laryngoscope; 2005 May; 115(5):832-6. PubMed ID: 15867649
[TBL] [Abstract][Full Text] [Related]
31. Socio-economic status covaries with central nervous system serotonergic responsivity as a function of allelic variation in the serotonin transporter gene-linked polymorphic region.
Manuck SB; Flory JD; Ferrell RE; Muldoon MF
Psychoneuroendocrinology; 2004 Jun; 29(5):651-68. PubMed ID: 15041087
[TBL] [Abstract][Full Text] [Related]
32. Familial migraine with aura: association study with 5-HT1B/1D, 5-HT2C, and hSERT polymorphisms.
Racchi M; Leone M; Porrello E; Rigamonti A; Govoni S; Sironi M; Montomoli C; Bussone G
Headache; 2004 Apr; 44(4):311-7. PubMed ID: 15109354
[TBL] [Abstract][Full Text] [Related]
33. Hepatocyte growth factor suppresses vascular medial hyperplasia and matrix accumulation in advanced pulmonary hypertension of rats.
Ono M; Sawa Y; Mizuno S; Fukushima N; Ichikawa H; Bessho K; Nakamura T; Matsuda H
Circulation; 2004 Nov; 110(18):2896-902. PubMed ID: 15505094
[TBL] [Abstract][Full Text] [Related]
34. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene.
Eddahibi S; Hanoun N; Lanfumey L; Lesch KP; Raffestin B; Hamon M; Adnot S
J Clin Invest; 2000 Jun; 105(11):1555-62. PubMed ID: 10841514
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the serotonin transporter gene linked polymorphism (5-HTTLPR) in anorexia nervosa.
Sundaramurthy D; Pieri LF; Gape H; Markham AF; Campbell DA
Am J Med Genet; 2000 Feb; 96(1):53-5. PubMed ID: 10686552
[TBL] [Abstract][Full Text] [Related]
36. Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor).
Johann M; Bobbe G; Putzhammer A; Wodarz N
Alcohol Clin Exp Res; 2003 Oct; 27(10):1527-34. PubMed ID: 14574222
[TBL] [Abstract][Full Text] [Related]
37. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension.
Guignabert C; Izikki M; Tu LI; Li Z; Zadigue P; Barlier-Mur AM; Hanoun N; Rodman D; Hamon M; Adnot S; Eddahibi S
Circ Res; 2006 May; 98(10):1323-30. PubMed ID: 16614302
[TBL] [Abstract][Full Text] [Related]
38. A functional serotonin transporter gene polymorphism is associated with migraine with aura.
Marziniak M; Mössner R; Schmitt A; Lesch KP; Sommer C
Neurology; 2005 Jan; 64(1):157-9. PubMed ID: 15642926
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in the serotonin transporter protein (SERT) gene in patients with pulmonary arterial hypertension.
Baloira A; Núñez M; Cifrian J; Vilariño C; Ojeda M; Valverde D
Arch Bronconeumol; 2012 Mar; 48(3):77-80. PubMed ID: 22177971
[TBL] [Abstract][Full Text] [Related]
40. Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples.
Persico AM; Militerni R; Bravaccio C; Schneider C; Melmed R; Conciatori M; Damiani V; Baldi A; Keller F
Am J Med Genet; 2000 Feb; 96(1):123-7. PubMed ID: 10686565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
